Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF)

Heart failure (HF) is associated with decreased quality of life, high re-admission rate and poor prognosis. In particular, ischemic heart failure (IHF) has a worse prognosis than nonischemic HF. The use of traditional Chinese medicine (TCM) alongside Western medicine to treat HF has developed into a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Trials 2013-05, Vol.14 (1), p.138-138, Article 138
Hauptverfasser:	Hou, Ya Zhu, Wang, Shuai, Zhao, Zhi Qiang, Wang, Xian Liang, Li, Bin, Soh, Shan Bin, Mao, Jing Yuan
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers - blood Cardiovascular Agents - adverse effects Cardiovascular Agents - therapeutic use Care and treatment China Double-Blind Method Drug Therapy, Combination Drugs, Chinese Herbal - adverse effects Drugs, Chinese Herbal - therapeutic use Exercise Test Exercise Tolerance - drug effects Health aspects Heart failure Heart Failure - blood Heart Failure - diagnosis Heart Failure - drug therapy Heart Failure - etiology Heart Failure - mortality Heart Failure - physiopathology Hospitalization Humans Lipids - blood Medicine, Chinese Mortality Myocardial Ischemia - blood Myocardial Ischemia - complications Myocardial Ischemia - mortality Myocardial Ischemia - physiopathology Natriuretic Peptide, Brain - blood Predictive Value of Tests Quality of Life Recovery of Function Research Design Stroke Volume - drug effects Study Protocol Time Factors Treatment Outcome Ventricular Function, Left - drug effects Walking
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!